Dysthyroid optic neuropathy (DON) is a sight-threatening complication of thyroid eye disease and can lead to permanent vision loss if not treated early. Imaging with computed tomography (CT) or magnetic resonance imaging (MRI) can aid in the diagnosis and early recognition of DON. A number of quantitative and qualitative imaging features have been associated with DON. This article summarises the definition, prevalence, and utility of these radiological findings in the diagnosis of DON.
NeigelJMRootmanJBelkinRI, et al.Dysthyroid optic neuropathy. The crowded orbital apex syndrome. Ophthalmology1988; 95: 1515–1521. 1988/11/01. DOI: 10.1016/s0161-6420(88)32978-7.
2.
BurchHBWartofskyL. Graves’ ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev1993; 14: 747–793. 1993/12/01. DOI: 10.1210/edrv-14-6-747.
3.
GuptaRThomasRAlmukhtarF, et al.Visual morbidity in thyroid eye disease in Asian Indian patients. Indian J Ophthalmol2020; 68: 1622–1627. 2020/07/28. DOI: 10.4103/ijo.IJO_2284_19.
McKeagDLaneCLazarusJH, et al.Clinical features of dysthyroid optic neuropathy: a European group on Graves’ orbitopathy (EUGOGO) survey. Br J Ophthalmol2007; 91: 455–458. 2006/10/13. DOI: 10.1136/bjo.2006.094607.
6.
NugentRABelkinRINeigelJM, et al.Graves orbitopathy: correlation of CT and clinical findings. Radiology1990; 177: 675–682. 1990/12/01. DOI: 10.1148/radiology.177.3.2243967.
7.
BirchallDGoodallKLNobleJL, et al.Graves ophthalmopathy: intracranial fat prolapse on CT images as an indicator of optic nerve compression. Radiology1996; 200: 123–127.
8.
GiaconiJAKazimMRhoT, et al.CT Scan evidence of dysthyroid optic neuropathy. Ophthalmic Plast Reconstr Surg2002; 18: 177–182. 2002/05/22. DOI: 10.1097/00002341-200205000-00005.
9.
WeisEHeranMKJhambA, et al.Clinical and soft-tissue computed tomographic predictors of dysthyroid optic neuropathy: refinement of the constellation of findings at presentation. Arch Ophthalmol2011; 129: 1332–1336. 2011/10/12. DOI: 10.1001/archophthalmol.2011.276.
10.
GonçalvesACSilvaLNGebrimEM, et al.Predicting dysthyroid optic neuropathy using computed tomography volumetric analyses of orbital structures. Clinics (Sao Paulo)2012; 67: 891–896. 2012/09/06. DOI: 10.6061/clinics/2012(08)06.
11.
BarrettLGlattHJBurdeRM, et al.Optic nerve dysfunction in thyroid eye disease: cT. Radiology1988; 167: 503–507. 1988/05/01. DOI: 10.1148/radiology.167.2.3357962.
12.
KemchoknateePChenkhumwongseADheeradilokT, et al.Diagnostic ability of Barrett's Index and presence of intracranial fat prolapse in dysthyroid optic neuropathy. Clin Ophthalmol2022; 16: 2569–2578. 2022/08/20. DOI: 10.2147/opth.S364987.
13.
Rutkowska-HincBMajEJabłońskaA, et al.Prevalence of radiological signs of dysthyroid optic neuropathy in magnetic resonance imaging in patients with active, moderate-to-severe, and very severe graves orbitopathy. Eur Thyroid J2018; 7: 88–94. 2018/03/30. DOI: 10.1159/000486828.
14.
MonteiroMLGonçalvesACSilvaCT, et al.Diagnostic ability of Barrett's index to detect dysthyroid optic neuropathy using multidetector computed tomography. Clinics (Sao Paulo)2008; 63: 301–306. 2008/06/24. DOI: 10.1590/s1807-59322008000300003.
15.
FeldonSELeeCPMuramatsuSK, et al.Quantitative computed tomography of Graves’ ophthalmopathy. Extraocular muscle and orbital fat in development of optic neuropathy. Arch Ophthalmol1985; 103: 213–215. DOI: 10.1001/archopht.1985.01050020065021.
16.
ZhangTChenRYeH, et al.Orbital MRI 3D reconstruction based on volume rendering in evaluating dysthyroid optic neuropathy. Curr Eye Res2022; 47: 1179–1185. 2022/05/24. DOI: 10.1080/02713683.2022.2066697.
17.
WeisEHeranMKJhambA, et al.Quantitative computed tomographic predictors of compressive optic neuropathy in patients with thyroid orbitopathy: a volumetric analysis. Ophthalmology2012; 119: 2174–2178. 2012/06/20. DOI: 10.1016/j.ophtha.2012.04.021.
18.
BergerMMatlachJPitzS, et al.Imaging of the medial rectus muscle predicts the development of optic neuropathy in thyroid eye disease. Sci Rep2022; 12: 6259. 2022/04/17. DOI: 10.1038/s41598-022-10043-z.
19.
ChanLLTanHEFook-ChongS, et al.Graves ophthalmopathy: the bony orbit in optic neuropathy, its apical angular capacity, and impact on prediction of risk. AJNR Am J Neuroradiol2009; 30: 597–602. 2009/01/17. DOI: 10.3174/ajnr.A1413.
20.
OropesaSDunbarKEGodfreyKJ, et al.Predominant contribution of superior Rectus-levator Complex enlargement to optic neuropathy and Inferior visual field defects in thyroid eye disease. Ophthalmic Plast Reconstr Surg2019; 35: 262–265. 2018/08/21. DOI: 10.1097/iop.0000000000001224.
21.
StarksVSReinshagenKLLeeNG, et al.Visual field and orbital computed tomography correlation in dysthyroid optic neuropathy due to thyroid eye disease. Orbit2020; 39: 77–83. 2019/05/07. DOI: 10.1080/01676830.2019.1600150.
22.
ChagantiSMundyKDeLisiMP, et al.Assessment of orbital computed tomography (CT) imaging biomarkers in patients with thyroid eye disease. J Digit Imaging2019; 32: 987–994. DOI: https://doi.org/10.1007/s10278-019-00195-2.
23.
ChengSMingYHuM, et al.Risk prediction of dysthyroid optic neuropathy based on CT imaging features combined the bony orbit with the soft tissue structures. Front Med (Lausanne)2022; 9: 936819. 2022/09/13. DOI: 10.3389/fmed.2022.936819.
24.
YuBGongCJiYF, et al.Predictive parameters on CT scan for dysthyroid optic neuropathy. Int J Ophthalmol2020; 13: 1266–1271. 2020/08/22. DOI: 10.18240/ijo.2020.08.13.
25.
GonçalvesACSilvaLNGebrimEM, et al.Quantification of orbital apex crowding for screening of dysthyroid optic neuropathy using multidetector CT. AJNR Am J Neuroradiol2012; 33: 1602–1607. 2012/03/24. DOI: 10.3174/ajnr.A3029.
26.
OzgenAAydingözU. Normative measurements of orbital structures using MRI. J Comput Assist Tomogr2000; 24: 493–496. 2000/06/23. DOI: 10.1097/00004728-200005000-00025.
27.
LimaBRPerryJD. Superior ophthalmic vein enlargement and increased muscle index in dysthyroid optic neuropathy. Ophthalmic Plast Reconstr Surg2013; 29: 147–149. 2013/03/01. DOI: 10.1097/IOP.0b013e3182831bd8.
28.
GaoYChangQLiY, et al.Correlation between extent of lacrimal gland prolapse and clinical features of thyroid-associated ophthalmopathy: a retrospective observational study. BMC Ophthalmol2022; 22: 66. DOI: 10.1186/s12886-022-02270-9.
29.
GagliardoCRadelliniSMorreale BubellaR, et al.Lacrimal gland herniation in graves ophthalmopathy: a simple and useful MRI biomarker of disease activity. Eur Radiol2020; 30: 2138–2141. DOI: 10.1007/s00330-019-06570-5.
30.
NaikMN. Orbital imaging for orbital decompression. In: RathSNaikMN (eds) Surgery in thyroid eye disease: a conceptual approach. Singapore: Springer Singapore, 2020, pp.37–50.
31.
RanaKJuniatVYongW, et al.Normative globe position values on orbital computed tomography in Australians. Can J Ophthalmol2022: S0008-4182(22)00168-5. 2022/06/01. DOI: 10.1016/j.jcjo.2022.05.004.
32.
RoseGEVahdaniK. Optic nerve stretch is unlikely to be a significant causative factor in dysthyroid optic neuropathy. Ophthalmic Plast Reconstr Surg2020; 36: 157–163. 2019/11/20. DOI: 10.1097/iop.0000000000001501.
33.
NandaTDunbarKECampbellAA, et al.Greater proptosis is not associated with improved compressive optic neuropathy in thyroid eye disease. Ophthalmic Plast Reconstr Surg2018; 34: S72–s74. 2018/06/01. DOI: 10.1097/iop.0000000000001134.
34.
ChagantiSMundyKDeLisiMP, et al.Assessment of orbital computed tomography (CT) imaging biomarkers in patients with thyroid eye disease. J Digit Imaging2019; 32: 987–994. 2019/06/15. DOI: 10.1007/s10278-019-00195-2.
35.
LiuPLuoBZhaiLH, et al.Multi-Parametric diffusion tensor imaging of the optic nerve for detection of dysthyroid optic neuropathy in patients with thyroid-associated ophthalmopathy. Front Endocrinol (Lausanne)2022; 13: 851143. 2022/05/21. DOI: 10.3389/fendo.2022.851143.
36.
ZouMWuDZhuH, et al.Multiparametric quantitative MRI for the evaluation of dysthyroid optic neuropathy. Eur Radiol2022; 32: 1931–1938. 2021/10/14. DOI: 10.1007/s00330-021-08300-2.
37.
AndersonRLTweetenJPPatrinelyJR, et al.Dysthyroid optic neuropathy without extraocular muscle involvement. Ophthalmic Surg1989; 20: 568–574. 1989/08/01.
38.
BainACMeaneyDF. Tissue-level thresholds for axonal damage in an experimental model of central nervous system white matter injury. J Biomech Eng2000; 122: 615–622. 2001/02/24. DOI: 10.1115/1.1324667.
39.
UgradarSRootmanDB. Quantification of optic nerve length and tortuosity in thyroid eye disease. Can J Ophthalmol2019; 54: 611–614. 2019/10/01. DOI: 10.1016/j.jcjo.2019.01.007.
40.
WuHLuoBYuanG, et al.The diagnostic value of the IDEAL-T2WI sequence in dysthyroid optic neuropathy: a quantitative analysis of the optic nerve and cerebrospinal fluid in the optic nerve sheath. Eur Radiol2021; 31: 7419–7428. 2021/05/17. DOI: 10.1007/s00330-021-08030-5.
41.
HuHChenHHChenW, et al.Thyroid-Associated ophthalmopathy: preliminary study using T2 mapping to characterize intraorbital optic nerve changes before dysthyroid optic neuropathy. Endocr Pract2021; 27: 191–197. 2021/02/26. DOI: 10.1016/j.eprac.2020.09.006.
42.
ÖzkanBAnikYKatreB, et al.Quantitative assessment of optic nerve with diffusion tensor imaging in patients with thyroid orbitopathy. Ophthalmic Plast Reconstr Surg2015; 31: 391–395. 2014/12/31. DOI: 10.1097/iop.0000000000000359.
